Helix BioMedix (HXBM) Financial Statements
Helix BioMedix Financial Overview
Helix BioMedix's market cap is currently $739.29K. The company's EPS TTM is ―; its P/E ratio is -1.34; Helix BioMedix has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 807.19K | $ 997.73K | $ 1.75M | $ 2.37M | $ 1.84M |
| Gross Profit | $ 802.01K | $ 987.98K | $ 1.74M | $ 1.93M | $ 1.73M |
| Operating Income | $ -595.81K | $ -984.05K | $ -1.08M | $ -1.32M | $ -1.23M |
| EBITDA | $ -546.33K | $ -1.05M | $ -1.18M | $ -995.41K | $ -1.19M |
| Net Income | $ -551.51K | $ -1.06M | $ -1.19M | $ -1.36M | $ -1.85M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 1.27M | $ 2.57M | $ 3.43M | $ 4.16M | $ 4.87M |
| Total Assets | $ 1.68M | $ 3.03M | $ 3.93M | $ 4.84M | $ 5.64M |
| Total Debt | $ 0.00 | $ 0.00 | $ 71.20K | $ 0.00 | $ 2.92M |
| Net Debt | $ -1.27M | $ -2.57M | $ -3.36M | $ -2.91M | $ -1.96M |
| Total Liabilities | $ 137.63K | $ 66.93K | $ 126.24K | $ 107.59K | $ 3.40M |
| Stockholders' Equity | $ 1.54M | $ 2.96M | $ 3.80M | $ 4.73M | $ 2.24M |
| Cash Flow | |||||
| Free Cash Flow | $ -601.07K | $ -871.53K | $ -729.08K | $ -862.27K | $ -708.46K |
| Operating Cash Flow | $ -601.07K | $ -870.21K | $ -727.73K | $ -854.67K | $ -667.33K |
| Investing Cash Flow | $ 0.00 | $ 6.25K | $ 1.25M | $ -257.25K | $ -41.13K |
| Financing Cash Flow | $ 0.00 | $ 0.00 | $ 0.00 | $ 151.90K | $ 140.39K |
Currency in USD
